Tuberculosis: all 1,435 studies
Page 13 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Appropriate Timing of HAART in Co-infected HIV/TB PatientsTerminatedNCT01014481Phase 4
- Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary TuberculosisCompletedNCT01011543Not applicable
- A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis(TB) Subunit VaccineCompletedNCT01003093Phase 1
- Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis MedicamentCompletedNCT01002170
- Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy VolunteersCompletedNCT00992069Phase 1
- Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult VolunteersCompletedNCT00990990Phase 1
- The Clinical Utility of QuantiFERON in the Diagnosis of Active TuberculosisCompletedNCT00982969
- The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis ExposureCompletedNCT00981071
- Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) DrugsCompletedNCT00979290
- Study of Health Personnel and the Assistance to Patients With Tuberculosis in Hospital EnvironmentCompletedNCT00978510
- Mentor Mothers: A Sustainable Family Intervention in South African TownshipsCompletedNCT00972699Phase 2
- Diagnosis of Latent Tuberculosis(TB) Infection in Health Care Workers Using TST and Whole Blood Interferon-γ AssayCompletedNCT00962793
- Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised PatientsCompletedNCT00962676
- Pharmacokinetic Study for Anti-tuberculosis DrugsStatus unknownNCT00948077Not applicable
- Improving Latent Tuberculosis (TB) Diagnosis in Thai ChildrenCompletedNCT00947609
- The Effectiveness of Health Facility-based and Community-based Care for TuberculosisCompletedNCT00939419Phase 4
- Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary TuberculosisCompletedNCT00933790Phase 3
- A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)Status unknownNCT00932854Not applicable
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectivenessCompletedNCT00931736Phase 3
- Anti-tuberculosis (TB) Drug Levels and HepatotoxicityCompletedNCT00929786
- A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive VolunteersCompletedNCT00929396Phase 1
- Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary TuberculosisStatus unknownNCT00926601
- Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha TherapyStatus unknownNCT00925249
- Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult VolunteersCompletedNCT00922363Phase 1
- Impact of Vitamin D Supplementation on Host Immunity to Mycobacterium Tuberculosis and Response to TreatmentCompletedNCT00918086Phase 2
- Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal AdenopathyCompletedNCT00915330Not applicable
- Demonstration of the Dynamic Hypothesis of Latent Tuberculosis InfectionStatus unknownNCT00905970
- Study of Latent Tuberculosis Infection (LTBI) by High Resolution ScannerStatus unknownNCT00904956
- The Role of High Resolution-Computed Tomography (CT) in Tuberculosis (TB) Outbreak InvestigationCompletedNCT00889759
- Interaction of Buprenorphine With HIV Medications and Tuberculosis MedicationsCompletedNCT00877591Phase 1
- Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy AdultsCompletedNCT00871949Phase 1
- Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected IndividualsCompletedNCT00865826
- Arginine as an Adjuvant Treatment Against TuberculosisCompletedNCT00857402Not applicable
- Deworming Against TuberculosisCompletedNCT00857116Not applicable
- Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in KenyaCompletedNCT00850915Phase 4
- Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced HepatitisCompletedNCT00834353
- TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy VolunteerCompletedNCT00828529Phase 1
- Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active TuberculosisCompletedNCT00822315Phase 2
- Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat TuberculosisCompletedNCT00816426Phase 1
- Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF TherapyCompletedNCT00811343Not applicable
- A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous PericarditisCompletedNCT00810849Phase 3
- Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected PatientsCompletedNCT00805272Not applicable
- Improving Community Based Tuberculosis Care in EthiopiaCompletedNCT00803322
- Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected ChildrenCompletedNCT00802802Phase 1
- Micronutrient Supplementation in in Paediatric Pulmonary TuberculosisCompletedNCT00801606Phase 3
- Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis VaccineTerminatedNCT00800670Phase 1
- Quantiferon for Detection of Latent Tuberculosis in Healthcare WorkersCompletedNCT00797836Phase 4
- Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal AdministrationCompletedNCT00793702Phase 1
- Vitamin D in Active Tuberculosis (TB) StudyWithdrawnNCT00788320Not applicable
- Spatial Epidemiology of Tuberculosis (TB) InfectionStatus unknownNCT00780546
- Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary TuberculosisCompletedNCT00772408
- An Evaluation of the Pharmacological Interaction of Lopinavir/r and RifampinCompletedNCT00771498Phase 4
- Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in PrisonCompletedNCT00767975Phase 3
- Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?CompletedNCT00763295
- Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary TuberculosisCompletedNCT00760149Phase 2
- Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?CompletedNCT00756808
- Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male VolunteersCompletedNCT00749034Phase 1
- A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult SubjectsTerminatedNCT00743470Phase 1
- TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.CompletedNCT00741169Phase 1
- Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) TreatmentTerminatedNCT00737724Not applicable
- A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIVCompletedNCT00731471Phase 1
- Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative AdultsCompletedNCT00730795Phase 1
- NAT2 in Re-challenge of INH in Patients With HepatitisStatus unknownNCT00728546Phase 4
- T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised IndividualsCompletedNCT00707317
- Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) PatientsStatus unknownNCT00698386Phase 3
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated TuberculosisCompletedNCT00698334Phase 3
- Detection of Latent Tuberculosis in Hemodialysis PatientsCompletedNCT00695734
- Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infectionStatus unknownNCT00692809
- Latent Tuberculosis Infection in Renal Transplant RecipientsCompletedNCT00682045
- A Study of MVA85A in Healthy Children and InfantsCompletedNCT00679159Phase 2
- L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)CompletedNCT00677339Phase 3
- Effectiveness of Alcohol Interventions Among Tuberculosis (TB) Patients in Tomsk Oblast, RussiaCompletedNCT00675961Not applicable
- A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85ACompletedNCT00653770Phase 1
- A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG VaccinationCompletedNCT00653627Phase 1
- Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in VietnamCompletedNCT00651066Phase 2
- Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOTCompletedNCT00647205Phase 4
- Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular NeovascularizationCompletedNCT00645697
- Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South AfricaCompletedNCT00640887Phase 2
- Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan PatientsStatus unknownNCT00620438Phase 4
- Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for TuberculosisCompletedNCT00617643Phase 4
- Rapid Diagnosis of Pulmonary TuberculosisStatus unknownNCT00608790Not applicable
- Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected ChildrenCompletedNCT00604617
- Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic RegionCompletedNCT00600782Phase 2
- Results of an Interferon-Gamma Release Assay After Treatment for TuberculosisCompletedNCT00595907
- Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)TerminatedNCT00571753Phase 3
- Co-Infection of NTM in Patients With Smear Positive Pulmonary TBCompletedNCT00567151
- Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver ToxicityCompletedNCT00564642Not applicable
- Continuous Positive Airway Pressure on Tuberculosis Pleural EffusionCompletedNCT00560521Not applicable
- Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent TuberculosisWithdrawnNCT00558480Not applicable
- Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration AreaCompletedNCT00557765
- Follow up of Autoantibodies in Active TuberculosisStatus unknownNCT00551226
- T-Cell Turnover Following Vaccination With MVA85ACompletedNCT00548444Phase 1
- Diagnosis of Tuberculosis Infection in HIV Co-infected ChildrenCompletedNCT00541294
- Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mgTerminatedNCT00533390Phase 4
- Drainage of Tuberculous Pleural EffusionsCompletedNCT00524147Not applicable
- TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive TuberculosisCompletedNCT00523926Phase 2
- A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIVTerminatedNCT00523458Phase 4
- Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis TreatmentWithdrawnNCT00517231
- High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant TuberculosisCompletedNCT00513396Phase 2/3
- Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)Status unknownNCT00512330